We are live on
!
Find out more
Royce & Associates Portfolio holdings
AUM
$12.4B
Turnover
20.64%
1-Year Est. Return
64.17%
This Fund
S&P 500
This Quarter
Est. Return
+7.76%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$10.3B
AUM Growth
+$309M
(+3.1%)
Cap. Flow
-$203M
Cap. Flow
% of AUM
-1.97%
Top 10 Holdings %
Top 10 Hldgs %
9.13%
Holding
981
New
70
Increased
333
Reduced
365
Closed
69
Avg Time Held
4.4
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AVID
Avid Technology Inc
AVID
|
+$16.3M |
| 2 |
Assured Guaranty
AGO
|
+$14.9M |
| 3 |
Crane NXT
CXT
|
+$13.8M |
| 4 |
Western Alliance Bancorporation
WAL
|
+$13.1M |
| 5 |
Bankunited
BKU
|
+$13.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CIRCOR International, Inc
CIR
|
+$42.4M |
| 2 |
First Citizens BancShares
FCNCA
|
+$39.3M |
| 3 |
FRG
Franchise Group, Inc.
FRG
|
+$31.1M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
+$17.2M |
| 5 |
Ares Management
ARES
|
+$17.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 28.83% |
| 2 | Technology | 19.34% |
| 3 | Consumer Discretionary | 12.72% |
| 4 | Financials | 12.33% |
| 5 | Materials | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
901
Torrid Holdings
CURV
$234M
| $83.9K | ﹤0.01% |
29,867
+18,657
| +166% | +$59.6K |
2022 Q3
3 quarters
|
|
902
DELISTED
First Foundation Inc
FFWM
| $83.9K | ﹤0.01% |
+21,136
| New | +$109K |
2023 Q2
0 quarters
|
|
903
Bel Fuse Inc Class B
BELFB
$3B
| $79.9K | ﹤0.01% |
+1,392
| New | +$63.7K |
2023 Q2
0 quarters
|
|
904
W&T Offshore
WTI
$574M
| $79.2K | ﹤0.01% |
+20,458
| New | +$88K |
2023 Q2
0 quarters
|
|
905
Caribou Biosciences
CRBU
$50.4M
| $62.5K | ﹤0.01% |
14,700
| – | – |
2022 Q4
2 quarters
|
|
906
Epsilon Energy
EPSN
$181M
| $61.5K | ﹤0.01% |
+11,525
| New | +$59.6K |
2023 Q2
0 quarters
|
|
907
DELISTED
Assertio
ASRT
| $58.3K | ﹤0.01% |
+717
| New | +$66.6K |
2023 Q2
0 quarters
|
|
908
SVRN, Inc. Common Stock
SVRN
$65.7M
| $42.9K | ﹤0.01% |
+52
| New | +$116K |
2023 Q2
0 quarters
|
|
909
Paysign
PAYS
$836M
| $40.1K | ﹤0.01% |
+16,376
| New | +$50.4K |
2023 Q2
0 quarters
|
|
910
Spero Therapeutics
SPRO
$64.1M
| $33.1K | ﹤0.01% |
+22,851
| New | +$39.1K |
2023 Q2
0 quarters
|
|
911
Spire Global
SPIR
$350M
| $25.8K | ﹤0.01% |
6,250
| – | – |
2022 Q1
5 quarters
|
|
|
CANO.WS
912
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
| $10.5K | ﹤0.01% |
49,999
| – | – |
2021 Q2
8 quarters
|
|
913
Albany International
AIN
$1.72B
| – | – |
-4,820
| Closed | -$431K | – |
|
914
Ambarella
AMBA
$2.72B
| – | – |
-28,100
| Closed | -$2.18M | – |
|
915
Amphastar Pharmaceuticals
AMPH
$1.1B
| – | – |
-22,315
| Closed | -$837K | – |
|
916
Apogee Enterprises
APOG
$865M
| – | – |
-11,809
| Closed | -$511K | – |
|
917
Antero Resources
AR
$11.9B
| – | – |
-44,535
| Closed | -$1.03M | – |
|
918
Everforth Inc
EFOR
$1.57B
| – | – |
-22,000
| Closed | -$1.82M | – |
|
919
Cisco
CSCO
$423B
| – | – |
-38,000
| Closed | -$1.99M | – |
|
920
DELISTED
CSG Systems International
CSGS
| – | – |
-7,354
| Closed | -$395K | – |
|
921
Cushman & Wakefield Ltd
CWK
$2.65B
| – | – |
-25,000
| Closed | -$264K | – |
|
922
Eastern Bankshares
EBC
$4.87B
| – | – |
-135,000
| Closed | -$1.7M | – |
|
923
Future Fuel
FF
$245M
| – | – |
-86,490
| Closed | -$638K | – |
|
924
Financial Institutions
FISI
$775M
| – | – |
-84,357
| Closed | -$1.63M | – |
|
925
First United
FUNC
$286M
| – | – |
-24,307
| Closed | -$410K | – |
|
Similar funds
Royce & Associates's Q2 2023 Portfolio in Review
As of Q2 2023, Royce & Associates held 981 positions worth $10.3B, up 3.1% from $9.99B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Royce & Associates's Q2 2023 filing shows 70 new, 333 increased, 365 reduced and 69 closed positions. Its largest new stake was Equity Commonwealth: 620,020 shares worth $12.6M. The largest sale was CIRCOR International, Inc, an estimated $42.4M.
By sector, the portfolio is most concentrated in Industrials at 29% of assets, up from 28% a quarter earlier, followed by Technology and Consumer Discretionary.
- Royce & Associates's largest Q2 2023 buy was Equity Commonwealth: 620,020 shares worth $12.6M.
- Royce & Associates added most to Avid Technology Inc in Q2 2023, an estimated $16.3M increase.
- Royce & Associates's biggest Q2 2023 reduction was First Citizens BancShares, cutting an estimated $39.3M.
- Royce & Associates fully exited CIRCOR International, Inc in Q2 2023, selling an estimated $42.4M.
- Royce & Associates's ten largest holdings make up 9.1% of its $10.3B portfolio in Q2 2023.
- Royce & Associates opened 70 new positions and closed 69 in Q2 2023.
- Royce & Associates's portfolio value rose 3.1% quarter-over-quarter to $10.3B.
Based on Royce & Associates's 13F filing for Q2 2023, filed 7 Aug 2023.